Jeffrey W. Runge
CIK 1479091 · last filed 2023-11-13
Jeffrey W. Runge is a corporate insider who has filed 21 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for ADTX, was dated Nov 13, 2023. Across all open-market trades the lifetime net is +$103.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $41 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$41
3
21
$103.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADTX | Director | 3,200 | $0.01 | $41 | $29.3K | 5 | 2023-11-13 |
| Altimmune, Inc. (PIP) Delisted | Director | 217,700 | — | — | $74.1K | 12 | 2017-01-24 |
| Conmed Healthcare Management, Inc. (CONM) Delisted | Director | 0 | — | — | $0 | 4 | 2012-08-30 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-13 | ADTX | Grant (A) | — | $0 | EDGAR |
| 2021-10-01 | ADTX | Grant (A) | — | $0 | EDGAR |
| 2021-06-02 | ADTX | Buy (P) | +10,000 | $29.3K | EDGAR |
| 2020-10-16 | ADTX | Grant (A) | — | $0 | EDGAR |
| 2020-10-15 | ADTX | Disp (D) | — | $0 | EDGAR |
| 2017-01-24 | Altimmune, Inc. (PIP) Delisted | Exer (M) | +20,000 | $62.2K | EDGAR |
| 2016-11-30 | Altimmune, Inc. (PIP) Delisted | Exer (M) | +20,000 | $44.0K | EDGAR |
| 2016-09-19 | Altimmune, Inc. (PIP) Delisted | Exer (M) | +120,000 | $184.8K | EDGAR |
| 2016-06-03 | Altimmune, Inc. (PIP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-04 | Altimmune, Inc. (PIP) Delisted | Grant (A) | — | $0 | EDGAR |